Correlation Between Caribou Biosciences and EnGene Holdings
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and enGene Holdings Common, you can compare the effects of market volatilities on Caribou Biosciences and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and EnGene Holdings.
Diversification Opportunities for Caribou Biosciences and EnGene Holdings
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Caribou and EnGene is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and EnGene Holdings go up and down completely randomly.
Pair Corralation between Caribou Biosciences and EnGene Holdings
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 0.78 times more return on investment than EnGene Holdings. However, Caribou Biosciences is 1.29 times less risky than EnGene Holdings. It trades about 0.03 of its potential returns per unit of risk. enGene Holdings Common is currently generating about -0.01 per unit of risk. If you would invest 168.00 in Caribou Biosciences on September 25, 2024 and sell it today you would earn a total of 1.00 from holding Caribou Biosciences or generate 0.6% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 99.21% |
Values | Daily Returns |
Caribou Biosciences vs. enGene Holdings Common
Performance |
Timeline |
Caribou Biosciences |
enGene Holdings Common |
Caribou Biosciences and EnGene Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and EnGene Holdings
The main advantage of trading using opposite Caribou Biosciences and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
EnGene Holdings vs. Beam Therapeutics | EnGene Holdings vs. Caribou Biosciences | EnGene Holdings vs. Intellia Therapeutics | EnGene Holdings vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |